Europe • Frankfurt Stock Exchange • FRA:A58 • US0367521038
The current stock price of A58.DE is 277.5 EUR. In the past month the price decreased by -8.45%.
ChartMill assigns a technical rating of 2 / 10 to A58.DE.
ChartMill assigns a fundamental rating of 4 / 10 to A58.DE. A58.DE has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months A58.DE reported a non-GAAP Earnings per Share(EPS) of 25.38. The EPS decreased by -8.49% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.84% | ||
| ROA | 4.66% | ||
| ROE | 12.9% | ||
| Debt/Equity | 0.71 |
28 analysts have analysed A58.DE and the average price target is 338.62 EUR. This implies a price increase of 22.03% is expected in the next year compared to the current price of 277.5.
For the next year, analysts expect an EPS growth of -13.28% and a revenue growth -2.33% for A58.DE
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|
View all stocks in the Managed Health Care Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
ELEVANCE HEALTH INC
220 Virginia Avenue
Indianapolis INDIANA US
Employees: 103158
Phone: 18003311476
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. The company is headquartered in Indianapolis, Indiana. The company went IPO on 2001-10-30. The company operates as a health insurer in the United States. The firm operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
The current stock price of A58.DE is 277.5 EUR. The price decreased by -4.84% in the last trading session.
ELEVANCE HEALTH INC (A58.DE) has a dividend yield of 2.07%. The yearly dividend amount is currently 5.77.
A58.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
A58.DE stock is listed on the Frankfurt Stock Exchange exchange.
ELEVANCE HEALTH INC (A58.DE) will report earnings on 2026-04-20, before the market open.